B2V4B5 AF NFT

Probable dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihzxyuqo3i3fcqukspv5m2sesi5bt6yb32aykoe4cpsyg7ilbtzfy/metadata.json
IPFS of structure file: 
bafybeibydawhtww4h32tvljwyqqsbprd3i2qn76hn5pm7vidfgohbwkv7q/AF-B2V4B5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x21f7C119eB7500129A497A533ee353fC35d9745f
First NFT owner address (bech32): 
genesis1y8muzx0tw5qp9xjf0ffnac6nls6ajazl6aa7my
Current NFT ID #378197 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378197
Accession (UniProt):
B2V4B5
Name::
Probable dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V4B5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V4B5|RLMN_CLOBA Probable dual-specificity RNA methyltransferase RlmN OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=rlmN PE=3 SV=1 MKNILDYTLEELTLWMKENNESSFRAKQIMSWIYKDVRNFSDMRNMPKSLIAKLEENFEISLPEIEEIYKSELDGTEKFLFKFSDGNLIESVLMRYKHGNSICISTQIGCRMGCKFCASTIDGRIRNLTTGEILSQILVVQNYIGERISNVVLMGSGEPLDNYENVMKFLEVVSAEYGLNIGQRHITLSTCGIVPKIYELADKELSITLAISLHAFSDEKRKEIMPIANKYSIDEILNACKYFINKTKRRITFEYSLVKDVNDSKEDARALGKLLKGMLCHVNLIPVNEIKERTFKRSSKETIQDFANILSNLGIEVTVRREMGSDINAACGQLRRSYIKTQETRGE